13don MSN
Michigan to limit Medicaid coverage for weight loss drugs to people with diabetes, morbid obesity
Michigan lawmakers plan to save money in the state's Medicaid program by limiting the use of popular weight loss drugs to ...
"The Blind Side" star Quinton Aaron lost over 200 pounds after a near-drowning experience in Louisiana that he credits as ...
Shifting drinking patterns and rising health concerns have hit earnings, compounded by US tariffs, the impact of buoyant interest rates on consumer spending and even elevated commodity prices. The ...
After losing its leading position in obesity, changing its CEO and triggering a major company reorganization, the pressure is ...
Shifting drinking patterns and rising health concerns have hit earnings, compounded by US tariffs, the impact of buoyant ...
Despite success with injectable drugs pharma companies are investing heavily in tablets, long considered the holy grail of ...
Detailed price information for Novo Nordisk A/S ADR (NVO-N) from The Globe and Mail including charting and trades.
Danish food tech startup Matr Foods has raised €20M ($23M) in Series A funding for its mycelium meat, adding to €20M in debt ...
Omeros' stock surged over 150% after licensing zaltenibart to Novo Nordisk for $240M upfront, plus milestones and royalties. See why OMER is a Buy.
Zacks.com on MSN
NVO vs. GPCR: Which Obesity Stock is the Better Buy Right Now?
Novo Nordisk NVO and Structure Therapeutics GPCR have emerged as noteworthy companies in the obesity space. A market leader ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results